Silicon Valley Capital Partners’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Silicon Valley Capital Partners's OGN Position: Q1 2026 in Review
Silicon Valley Capital Partners increased its Organon & Co (OGN) stake by 1.2% in Q1 2026, buying an estimated $8 and bringing the position to 82 shares worth $490. The position accounts for ﹤0.01% of the portfolio, ranked #367.
Silicon Valley Capital Partners first reported a position in OGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.12K in Q4 2022. 604 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Silicon Valley Capital Partners held 82 shares of Organon & Co worth $490 as of Q1 2026.
- Silicon Valley Capital Partners bought 1 Organon & Co share in Q1 2026, an estimated $8.
- Organon & Co made up ﹤0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #367 holding.
- Silicon Valley Capital Partners first reported a position in Organon & Co in Q4 2022 and has held it in 14 quarters since.
- Silicon Valley Capital Partners's Organon & Co position peaked at $1.12K in Q4 2022.
- 604 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.